EPI-589

• UNSPSC Description:

  EPI-589, a quinone derivative, is a safe and well tolerated oxidoreductase?enzyme inhibitor. EPI-589 has the potential for the treatment of amyotrophic lateral sclerosis (ALS)[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/epi-589.html

• Purity:

  99.53

• Solubility:

  DMSO : 2 mg/mL (ultrasonic;warming;heat to 60°C)

• Smiles:

  CC1=C(C(C(CC[C@@](O)(C(N)=O)C)=C(C1=O)C)=O)C

• Molecular Weight:

  265.30

• References & Citations:

  [1]BioElectron’s EPI-589 Shows Positive Results in ALS Patients in Phase 2a Trial|[2]Phase IIa trial of EPI-589 in ALS shows improvement in CSF

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Clinical Information:

  Phase 2

• CAS Number:

  1147883-03-1